Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis
Laura Labriola, Anaïs Scohy, Elliott Van Regemorter, Arnaud Robert, Gaëtan Clerbaux, Gaëlle Gillerot, Jean-Michel Pochet, Pauline Biller, Manuel De Schuiteneer, Johann Morelle, Jean Cyr Yombi, Benoît Kabamba, Hector Rodriguez‐Villalobos, Michel Jadoul
Topics & Concepts
MedicineImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakCohortNursing homesMulticenter studySkilled Nursing FacilityMEDLINEHemodialysisCohort studyIntensive care medicineVirologyEmergency medicineInternal medicineImmunologyNursingOutbreakAntibodyRandomized controlled trialInfectious disease (medical specialty)Political scienceLawDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies